These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 2195547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.
    Orsini MJ, Debouck CM.
    J Virol; 1996 Nov; 70(11):8055-63. PubMed ID: 8892930
    [Abstract] [Full Text] [Related]

  • 6. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA.
    Virology; 1997 Jul 07; 233(2):339-57. PubMed ID: 9217057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization.
    Endo S, Kubota S, Siomi H, Adachi A, Oroszlan S, Maki M, Hatanaka M.
    Virus Genes; 1989 Nov 07; 3(2):99-110. PubMed ID: 2559542
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
    Rappaport J, Lee SJ, Khalili K, Wong-Staal F.
    New Biol; 1989 Oct 07; 1(1):101-10. PubMed ID: 2562188
    [Abstract] [Full Text] [Related]

  • 17. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J, Frankel AD.
    Proc Natl Acad Sci U S A; 1993 Feb 15; 90(4):1571-5. PubMed ID: 8434019
    [Abstract] [Full Text] [Related]

  • 18. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
    Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G.
    Nucleic Acids Res; 1989 May 11; 17(9):3551-61. PubMed ID: 2542902
    [Abstract] [Full Text] [Related]

  • 19. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.
    Kim YS, Panganiban AT.
    J Virol; 1993 Jul 11; 67(7):3739-47. PubMed ID: 8510203
    [Abstract] [Full Text] [Related]

  • 20. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5' long terminal repeat.
    Mallon R, Borkowski J, Albin R, Pepitoni S, Schwartz J, Kieff E.
    J Virol; 1990 Dec 11; 64(12):6282-5. PubMed ID: 2173793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.